1 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Nervous System Disease: new trials by email Literature Review of Nervous System Disease trials Research Report on Nervous System Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CMP-002 in Participants With SYNGAP1-Related Disorder CMP-002, Sham-prick - Nervous System Disease | Phase 1 / Phase 2 | Not yet recruiting | CAMP4 Therapeutics Corporation | 80 | 2026-11-01 | 2026-11-13 |
| PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome Brain PET Imaging with 11C Rolipram, Whole Body PET Baseline with 11C Rolipram, Whole Body PET Blocked with Roflumilast - Nervous System Disease | Phase 1 / Phase 2 | Completed | National Institute of Mental Health (NIMH) | 16 | 2018-04-04 | 2020-10-19 |
Nervous System Diseases (2) · Muscle Cramp (1)
Muscular Diseases (1) · Musculoskeletal Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Roflumilast (1)
CAMP4 Therapeutics Corporation (1) · National Institute of Mental Health (NIMH) (1)
Argentina (1) · United States (1)